Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)
Status:
RECRUITING
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The objective of this phase III, placebo-controlled platform study is to investigate the efficacy of drugs for patients with ALS (Amyotrophic lateral sclerosis).
Phase:
PHASE3
Details
Lead Sponsor:
Stichting TRICALS Foundation
Collaborators:
Alan Davidson Foundation Fight MND Luzon Foundation MNDA My name'5 Doddie Foundation Research Foundation Flanders Stichting ALS Nederland Thierry Latran Foundation Ulla-Carin Lindquist Foundation